Cargando…
YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer
BACKGROUND: Despite the availability of several treatments for non-muscle-invasive bladder cancer (NMIBC), many patients are still not responsive to treatments, and the disease progresses. A new prognostic classifier can differentiate between treatment response and progression, and it could be used...
Autores principales: | Baek, Seung-Woo, Mun, Jeong-Yeon, Jang, In-Hwan, Yang, Gi-Eun, Jeong, Mi-So, Kim, Seon-Kyu, Nam, Jong-Kil, Chu, In-Sun, Leem, Sun-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166372/ https://www.ncbi.nlm.nih.gov/pubmed/35665684 http://dx.doi.org/10.1016/j.ebiom.2022.104092 |
Ejemplares similares
-
Transcriptional Profiling of Advanced Urothelial Cancer Predicts Prognosis and Response to Immunotherapy
por: Baek, Seung-Woo, et al.
Publicado: (2020) -
Identification of an immunotherapy-responsive molecular subtype of bladder cancer
por: Song, Bic-Na, et al.
Publicado: (2019) -
Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells
por: Mun, Jeong-Yeon, et al.
Publicado: (2022) -
VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer
por: Kim, Min-Hye, et al.
Publicado: (2021) -
E2F1 Promotes Progression of Bladder Cancer by Modulating RAD54L Involved in Homologous Recombination Repair
por: Mun, Jeong-Yeon, et al.
Publicado: (2020)